Acura Pharmaceuticals, Inc. Share Price Nasdaq
Equities
US00509L7038
Biotechnology & Medical Research
Sales 2020 | 3.57M 298M | Sales 2021 | 1.56M 130M | Capitalization | 32.54M 2.71B |
---|---|---|---|---|---|
Net income 2020 | -1M -83.42M | Net income 2021 | - 0 | EV / Sales 2020 | 2.91 x |
Net Debt 2020 | 5.86M 488M | Net Debt 2021 | 135K 11.26M | EV / Sales 2021 | 20.9 x |
P/E ratio 2020 |
-5.25
x | P/E ratio 2021 |
-25
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 15.27% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 65 | 07/08/07 |
Peter Clemens
DFI | Director of Finance/CFO | 71 | 01/98/01 |
Bob Seiser
AUD | Comptroller/Controller/Auditor | 60 | 01/98/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Clemens
DFI | Director of Finance/CFO | 71 | 01/98/01 |
Bruce Wesson
BRD | Director/Board Member | 81 | 01/98/01 |
William Skelly
BRD | Director/Board Member | 73 | 01/96/01 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |